Home Drug Regulators Europe No-Deal Brexit: MHRA Would Take on EMA Functions for UK Medicine

No-Deal Brexit: MHRA Would Take on EMA Functions for UK Medicine

222
0

“The UK will fall outside of the European Medicines Agency (EMA) in the event of a no-deal Brexit, leaving the Medicines and Healthcare Products Regulatory Agency (MHRA) to take on the functions currently undertaken by the EU for medicines on the UK market.

That was confirmed in the government papers released yesterday, August 23, which provide guidance on how to prepare if there is no deal agreed when the UK leaves the EU in March 2019.”

LSIPR

LEAVE A REPLY

Please enter your comment!
Please enter your name here

This site uses Akismet to reduce spam. Learn how your comment data is processed.